SG10201405022PA - Ketoreductase polypeptides for the preparation of phenylephrine - Google Patents

Ketoreductase polypeptides for the preparation of phenylephrine

Info

Publication number
SG10201405022PA
SG10201405022PA SG10201405022PA SG10201405022PA SG10201405022PA SG 10201405022P A SG10201405022P A SG 10201405022PA SG 10201405022P A SG10201405022P A SG 10201405022PA SG 10201405022P A SG10201405022P A SG 10201405022PA SG 10201405022P A SG10201405022P A SG 10201405022PA
Authority
SG
Singapore
Prior art keywords
phenylephrine
preparation
ketoreductase polypeptides
ketoreductase
polypeptides
Prior art date
Application number
SG10201405022PA
Inventor
Oscar Alvizo
Steven J Collier
Joerg Hennemann
Seong Ho Oh
Wenjuan Zha
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of SG10201405022PA publication Critical patent/SG10201405022PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01184—Carbonyl reductase (NADPH) (1.1.1.184)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201405022PA 2009-08-19 2010-08-19 Ketoreductase polypeptides for the preparation of phenylephrine SG10201405022PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23532409P 2009-08-19 2009-08-19

Publications (1)

Publication Number Publication Date
SG10201405022PA true SG10201405022PA (en) 2014-10-30

Family

ID=43607588

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2012010864A SG178456A1 (en) 2009-08-19 2010-08-19 Ketoreductase polypeptides for the preparation of phenylephrine
SG10201405022PA SG10201405022PA (en) 2009-08-19 2010-08-19 Ketoreductase polypeptides for the preparation of phenylephrine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2012010864A SG178456A1 (en) 2009-08-19 2010-08-19 Ketoreductase polypeptides for the preparation of phenylephrine

Country Status (5)

Country Link
US (8) US9102959B2 (en)
EP (1) EP2467473B1 (en)
ES (1) ES2575560T3 (en)
SG (2) SG178456A1 (en)
WO (1) WO2011022548A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
JP5646328B2 (en) * 2007-10-01 2014-12-24 コデクシス， インコーポレイテッド Ketreductase polypeptide for the production of azetidinone
CN102186972B (en) * 2008-08-29 2014-08-20 科德克希思公司 Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
ES2575560T3 (en) 2009-08-19 2016-06-29 Codexis, Inc. Cetorreductase polypeptides to prepare phenylephrine
US9040262B2 (en) 2010-05-04 2015-05-26 Codexis, Inc. Biocatalysts for ezetimibe synthesis
HUE046089T2 (en) 2011-11-18 2020-01-28 Codexis Inc Biocatalysts for the preparation of hydroxy substituted carbamates
CN102776251B (en) * 2012-08-21 2013-11-13 尚科生物医药（上海）有限公司 Preparation method of phenylephrine
US8859623B1 (en) * 2013-11-14 2014-10-14 Paragon BioTeck, Inc. Methods and compositions of stable phenylephrine formulations
US10093905B2 (en) 2014-04-22 2018-10-09 C-Lecta Gmbh Ketoreductases
WO2017001907A1 (en) 2015-06-29 2017-01-05 Teva Pharmaceuticals International Gmbh Biocatalytic processes for the preparation of vilanterol
CN106566851B (en) * 2016-11-11 2020-11-10 苏州引航生物科技有限公司 Preparation method of chloramphenicol compound
CN106636239B (en) * 2016-11-16 2019-12-31 苏州引航生物科技有限公司 Preparation method of chloramphenicol
EP3652328A1 (en) 2017-07-14 2020-05-20 c-LEcta GmbH Ketoreductases
CN109576313B (en) * 2017-09-29 2022-02-22 尚科生物医药（上海）有限公司 Method for preparing (S) -2-chloro-1- (3-hydroxyphenyl) ethanol
CN109576312B (en) * 2017-09-29 2021-08-24 尚科生物医药（上海）有限公司 Method for preparing (R) -2-chloro-1- (3-hydroxyphenyl) ethanol
CN108410830B (en) * 2018-03-15 2021-06-25 尚科生物医药（上海）有限公司 Ketoreductase and method for preparing (S) -1- (2-chlorphenyl) ethanol by catalyzing ketoreductase
CN109456949A (en) * 2018-12-27 2019-03-12 尚科生物医药（上海）有限公司 A kind of Ketoreductase mutant being used to prepare R type neo-synephrine
CN118667775A (en) * 2023-03-14 2024-09-20 宁波酶赛生物工程有限公司 Biocatalyst and method for synthesizing chiral alcohol compound

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290385B1 (en) 1987-05-04 1992-10-21 Ciba-Geigy Ag Process for preparing 4-acyloxy-3-hydroxyethyl-azetidinones
US5538867A (en) 1988-09-13 1996-07-23 Elf Aquitaine Process for the electrochemical regeneration of pyridine cofactors
JPH0623150B2 (en) 1988-11-15 1994-03-30 高砂香料工業株式会社 Process for producing optically active 3-hydroxybutanoic acids
DE4014573C1 (en) 1990-05-07 1991-10-10 Forschungszentrum Juelich Gmbh, 5170 Juelich, De
US5225339A (en) 1992-02-26 1993-07-06 The Scripps Research Institute Lactobacillus kefir alcohol dehydrogenase
US5385833A (en) 1992-02-26 1995-01-31 The Scripps Research Institute Pseudomonas sp. ATCC No. 49794 alcohol dehydrogenase
JP3155107B2 (en) 1993-01-12 2001-04-09 ダイセル化学工業株式会社 Method for producing optically active 4-halo-3-hydroxybutyrate
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5427933A (en) 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
US5491077A (en) 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
EP0775210B1 (en) 1994-08-12 2000-02-02 Dsm N.V. Mutated penicillin g acylase genes
JPH08336393A (en) 1995-04-13 1996-12-24 Mitsubishi Chem Corp Production of optically active gamma-substituted-beta-hydroxybutyric ester
JP2948504B2 (en) 1995-05-11 1999-09-13 高砂香料工業株式会社 Method for producing optically active azetidin-2-one derivative
FI104465B (en) 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
US5618707A (en) 1996-01-04 1997-04-08 Schering Corporation Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof
DE19610984A1 (en) 1996-03-21 1997-09-25 Boehringer Mannheim Gmbh Alcohol dehydrogenase and its use for the enzymatic production of chiral hydroxy compounds
US5891685A (en) 1996-06-03 1999-04-06 Mitsubishi Chemical Corporation Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid
DK1036198T3 (en) 1997-12-08 2013-01-02 California Inst Of Techn Method for Preparation of Polynucleotide and Polypeptide Sequences
DE19812004A1 (en) 1998-03-19 1999-09-30 Forschungszentrum Juelich Gmbh Dehydrogenases with improved NAD dependence, their production and use
US6495023B1 (en) 1998-07-09 2002-12-17 Michigan State University Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
DE19857302C2 (en) 1998-12-14 2000-10-26 Forschungszentrum Juelich Gmbh Process for the enantioselective reduction of 3,5-dioxocarboxylic acids, their salts and esters
JP2000236883A (en) 1998-12-21 2000-09-05 Daicel Chem Ind Ltd New carbonyl reductase, production of the enzyme, dna coding for the enzyme, and production of alcohol using the same
JP4221100B2 (en) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 Semiconductor device
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU1551701A (en) 1999-12-03 2001-06-12 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
TWI275645B (en) 2000-02-16 2007-03-11 Daicel Chemical Industries Ltd. (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes
EP1272967A2 (en) 2000-03-30 2003-01-08 Maxygen, Inc. In silico cross-over site selection
DE10037101A1 (en) 2000-07-27 2002-02-07 Degussa Recombinantly produced enzymes with improved NAD (H) acceptance
US7202070B2 (en) 2000-10-31 2007-04-10 Biocatalytics, Inc. Method for reductive amination of a ketone using a mutated enzyme
WO2002077258A1 (en) 2001-03-22 2002-10-03 Bristol-Myers Squibb Company Stereoselective reduction of substituted acetophenone
CA2442219C (en) 2001-03-28 2007-09-11 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
DE10119274A1 (en) 2001-04-20 2002-10-31 Juelich Enzyme Products Gmbh Enzymatic process for the enantioselective reduction of keto compounds
BR0215329A (en) 2001-12-27 2004-11-16 Dsm Ip Assets Bv Process for preparing a b-lactam antibiotic
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US6900203B2 (en) 2002-06-19 2005-05-31 Polium Technologies, Inc. Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them
JP4213524B2 (en) 2003-04-17 2009-01-21 ダイセル化学工業株式会社 Novel carbonyl reductase, polynucleotide containing DNA encoding the enzyme, method for producing the same, and method for producing optically active alcohol using the same
DE10327454A1 (en) 2003-06-18 2005-01-20 Juelich Enzyme Products Gmbh Oxidoreductase from Pichia capsulata
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
BRPI0413492A (en) 2003-08-11 2006-10-17 Codexis Inc polypeptide, polynucleotide, isolated nucleic acid sequence, expression vector, host cell, method of making a gdh polypeptide, and, composition
AU2004266100A1 (en) 2003-08-11 2005-03-03 Codexis, Inc. Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters
DE10345772A1 (en) 2003-10-01 2005-04-21 Basf Ag Process for the preparation of 3-methylamino-1- (thien-2-yl) -propan-1-ol
EP1687287A1 (en) 2003-11-24 2006-08-09 Hetero Drugs Limited A novel process for ezetimibe intermediate
US20080050787A1 (en) 2003-12-02 2008-02-28 Hazuki Nagai Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol
WO2005077171A1 (en) * 2004-02-05 2005-08-25 Montana State University-Bozeman Amino acid compositions for seeds and their use in preventing herbicide damage to plants
US7393667B2 (en) 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
WO2007010944A1 (en) 2005-07-20 2007-01-25 Kaneka Corporation Method for producing optically active 2-(n-substituted aminomethyl)-3-hydroxybutyric acid ester
AT502395B1 (en) 2005-07-27 2007-03-15 Iep Gmbh OXIDOREDUCETASES FOR THE STEREOSELECTIVE REDUCTION OF KETOVER BINDINGS
CN101528917B (en) 2006-10-02 2015-07-29 科德克希思公司 The Statins pure for the preparation of stereoisomerism and the composition of synthetic intermediate thereof and method
JP2010517574A (en) * 2007-02-08 2010-05-27 コデクシス， インコーポレイテッド Ketreductase and uses thereof
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
US8748143B2 (en) 2007-09-13 2014-06-10 Codexis, Inc. Ketoreductase polypeptides for the reduction of acetophenones
CN101889081B (en) 2007-09-28 2014-06-18 科德克希思公司 Ketoreductase polypeptides and uses thereof
JP5646328B2 (en) * 2007-10-01 2014-12-24 コデクシス， インコーポレイテッド Ketreductase polypeptide for the production of azetidinone
WO2009086283A1 (en) 2007-12-21 2009-07-09 Cambrex Charles City, Inc. Synthesis of enantiomerically pure 2-hydroxy-2-aryl-ethylamines
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8288141B2 (en) 2008-08-27 2012-10-16 Codexis, Inc. Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
WO2010027710A2 (en) 2008-08-27 2010-03-11 Codexis, Inc. Ketoreductase polypeptides and uses thereof
WO2010025238A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
CN102186972B (en) 2008-08-29 2014-08-20 科德克希思公司 Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
US8617854B2 (en) 2008-09-17 2013-12-31 Basf Se Method for producing L-phenylephrine using an alcohol dehydrogenase of Aromatoleum aromaticum EBN1 (Azoarcus sp. EBN1)
ES2575560T3 (en) * 2009-08-19 2016-06-29 Codexis, Inc. Cetorreductase polypeptides to prepare phenylephrine

Also Published As

Publication number Publication date
US12031159B2 (en) 2024-07-09
US20150299671A1 (en) 2015-10-22
US10870835B2 (en) 2020-12-22
EP2467473A4 (en) 2013-03-20
US20120149073A1 (en) 2012-06-14
ES2575560T3 (en) 2016-06-29
WO2011022548A2 (en) 2011-02-24
US20200157511A1 (en) 2020-05-21
US10358631B2 (en) 2019-07-23
EP2467473B1 (en) 2016-03-23
US9834758B2 (en) 2017-12-05
US20180066239A1 (en) 2018-03-08
US20220267744A1 (en) 2022-08-25
US11345898B2 (en) 2022-05-31
SG178456A1 (en) 2012-04-27
US20240301366A1 (en) 2024-09-12
US20210062162A1 (en) 2021-03-04
US9102959B2 (en) 2015-08-11
US20190309267A1 (en) 2019-10-10
US10590396B2 (en) 2020-03-17
WO2011022548A3 (en) 2011-07-21
EP2467473A2 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
SG10201405022PA (en) Ketoreductase polypeptides for the preparation of phenylephrine
GB2474679B (en) Cartridge for the preparation of beverages
ZA201202504B (en) Process for the preparation of calcobutrol
IL220170A0 (en) New process for the preparation of dronedarone
IL215962A0 (en) Soilid preparation
GB2470472B (en) Liquid preparation
HUE066392T2 (en) Process for the preparation of fluoroalkyl fluoroformates
ZA201106546B (en) Zirconia powder
PL390042A1 (en) Process for the preparation of kvass
EP2460415A4 (en) Coated preparation
IL214906A (en) Process for the preparation of ajoene
EP2412366A4 (en) Solid preparation
EP2514422A4 (en) Elution-stabilized preparation
PL2412369T3 (en) Coated solid preparation
PL388931A1 (en) Process for the preparation of fluorocarbfunctional silesquioxanes
EP2412367A4 (en) Solid preparation
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
EP2481417A4 (en) Lactase preparation
GB0922537D0 (en) Pharmaceutical preparation
EP2459540A4 (en) Preparation of fipamezole
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
IL220160A (en) Process for the preparation of defferasirox
GB0910240D0 (en) Odontalgic preparation
PL389568A1 (en) Process for the preparation of 2-methylglycidol
GB0904311D0 (en) Processes for the preparation of compounds